Literature DB >> 7751859

Risk of recurrence after first unprovoked tonic-clonic seizure in adults.

I Bora1, B Seçkin, M Zarifoglu, F Turan, S Sadikoglu, E Ogul.   

Abstract

The likelihood of seizure recurrence after a first unprovoked seizure has profound social, vocational and emotional implications for the patients. Recurrence rates have varied between 27% and 71% in various studies, and the management of patients with a single unprovoked seizure is a controversial topic. In this prospective study we investigated the influence of age, sex, family history, EEG patterns, and anticonvulsant drug (ACD) therapy on seizure recurrence after a first unprovoked tonic-clonic seizure in adults. For this purpose, between October 1988 and January 1991, we studied adult patients who had experienced their after unprovoked tonic-clonic seizure within last 2 months before neurological consultation, and followed them until June 1993. There were 147 patients who met the criteria for inclusion. Overall cumulative recurrence rates were 31.8% by 6 months, 41.3% by 1 year, 44.1% by 2 years, 42.2% by 3 years, and 45.2% by 4 years. Among the risk factors that were evaluated, the time of the day at which the initial seizure occurred was associated significantly (P < 0.05) with seizure recurrence. In our series, 62 patients received ACD and 85 did not. We did not find a significant difference in recurrence rate with regard to ACD therapy. Our results are comparable with those of studies reported previously and suggest that the majority of recurrences after a first unprovoked seizure were seen in the first year (in our series 89% of all recurrences). In our study there was no significant predictor of seizure recurrence, except the time of day at which the initial seizure occurred.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751859     DOI: 10.1007/BF00936889

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Risk of recurrence after an initial unprovoked seizure.

Authors:  J F Annegers; S B Shirts; W A Hauser; L T Kurland
Journal:  Epilepsia       Date:  1986 Jan-Feb       Impact factor: 5.864

2.  Should people be treated after a first seizure?

Authors:  W A Hauser
Journal:  Arch Neurol       Date:  1986-12

3.  Prognosis of isolated seizures in adult life.

Authors:  P G Cleland; I Mosquera; W P Steward; J B Foster
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

4.  Epilepsy after a first unprovoked seizure in childhood.

Authors:  P R Camfield; C S Camfield; J M Dooley; J A Tibbles; T Fung; B Garner
Journal:  Neurology       Date:  1985-11       Impact factor: 9.910

5.  Seizure recurrence after a first unprovoked seizure.

Authors:  W A Hauser; V E Anderson; R B Loewenson; S M McRoberts
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

6.  Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study.

Authors:  S Shinnar; A T Berg; S L Moshé; M Petix; J Maytal; H Kang; E S Goldensohn; W A Hauser
Journal:  Pediatrics       Date:  1990-06       Impact factor: 7.124

7.  The risk of recurrence of nonfebrile seizures in children.

Authors:  D G Hirtz; J H Ellenberg; K B Nelson
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

8.  The temporal aspects of prognosis in epilepsy.

Authors:  S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

9.  Newly treated childhood epilepsy: a prospective study of recurrences and side effects.

Authors:  P R Camfield; C S Camfield; E C Smith; J A Tibbles
Journal:  Neurology       Date:  1985-05       Impact factor: 9.910

Review 10.  The first seizure in adult life. Value of clinical features, electroencephalography, and computerised tomographic scanning in prediction of seizure recurrence.

Authors:  A Hopkins; A Garman; C Clarke
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

View more
  8 in total

1.  Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  A Krumholz; S Wiebe; G S Gronseth; D S Gloss; A M Sanchez; A A Kabir; A T Liferidge; J P Martello; A M Kanner; S Shinnar; J L Hopp; J A French
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

Review 2.  Neurologic conditions: assessing medical fitness to drive.

Authors:  Steven H Yale; Phiroze Hansotia; Dawn Knapp; John Ehrfurth
Journal:  Clin Med Res       Date:  2003-07

3.  Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Allan Krumholz; Samuel Wiebe; Gary S Gronseth; David S Gloss; Ana M Sanchez; Arif A Kabir; Aisha T Liferidge; Justin P Martello; Andres M Kanner; Shlomo Shinnar; Jennifer L Hopp; Jacqueline A French
Journal:  Neurology       Date:  2015-04-21       Impact factor: 9.910

4.  Improvement of thoracic aortic vasoreactivity by continuous and intermittent exercise in high-fat diet-induced obese rats.

Authors:  Hongpeng Liu; Zhen Yang; Jian Hu; Yan Luo; Lingqin Zhu; Huifang Yang; Guanghua Li
Journal:  Biomed Rep       Date:  2015-04-16

5.  Clinical profile of Solitary Seizures.

Authors:  S K Jha
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Etiology and outcomes of new onset seizure in adult patients: A clinical experience from emergency department of a tertiary care center.

Authors:  Noman Ali; Hasnain Abbas Dharamshi; Syed Mustahsan; Suman Noorani
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

7.  Single Unprovoked Seizures.

Authors:  Susan T. Herman
Journal:  Curr Treat Options Neurol       Date:  2004-05       Impact factor: 3.598

Review 8.  Sleep and Epilepsy: a Focused Review of Pathophysiology, Clinical Syndromes, Co-morbidities, and Therapy.

Authors:  J Layne Moore; Diego Z Carvalho; Erik K St Louis; Carl Bazil
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.